BMA Relative Valuation
BMA's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BMA is overvalued; if below, it's undervalued.
Historical Valuation
Banco Macro SA (BMA) is now in the Fair zone, suggesting that its current forward PE ratio of 6.11 is considered Fairly compared with the five-year average of 6.16. The fair price of Banco Macro SA (BMA) is between 53.10 to 87.83 according to relative valuation methord.
Relative Value
Fair Zone
53.10-87.83
Current Price：64.54
Fair
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
12.02
P/B
Median3y
7.58
Median5y
4.90
-7.63
FCF Yield
Median3y
103.99
Median5y
99.83
Competitors Valuation Multiple
The average P/S ratio for BMA's competitors is 2.50, providing a benchmark for relative valuation. Banco Macro SA Corp (BMA) exhibits a P/S ratio of 1.40, which is -43.89% above the industry average. Given its robust revenue growth of -58.53%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
Revenue Growth
Market Cap
People Also Watch
FAQ
Is Banco Macro SA (BMA) currently overvalued or undervalued?
What is Banco Macro SA (BMA) fair value?
How does BMA's valuation metrics compare to the industry average?
What is the current P/B ratio for Banco Macro SA (BMA) as of Jul 19 2025?
What is the current FCF Yield for Banco Macro SA (BMA) as of Jul 19 2025?
What is the current Forward P/E ratio for Banco Macro SA (BMA) as of Jul 19 2025?